Advertisement
UK markets close in 3 hours 47 minutes
  • FTSE 100

    7,857.97
    -107.56 (-1.35%)
     
  • FTSE 250

    19,426.36
    -272.53 (-1.38%)
     
  • AIM

    741.48
    -8.80 (-1.17%)
     
  • GBP/EUR

    1.1707
    -0.0004 (-0.03%)
     
  • GBP/USD

    1.2450
    +0.0004 (+0.03%)
     
  • Bitcoin GBP

    50,239.73
    -2,903.21 (-5.46%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     
  • DOW

    37,735.11
    -248.13 (-0.65%)
     
  • CRUDE OIL

    85.03
    -0.38 (-0.44%)
     
  • GOLD FUTURES

    2,388.80
    +5.80 (+0.24%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • HANG SENG

    16,248.97
    -351.49 (-2.12%)
     
  • DAX

    17,835.57
    -191.01 (-1.06%)
     
  • CAC 40

    7,960.23
    -84.88 (-1.06%)
     

Global Safety Needles Market to Reach $2.9 Billion by 2027

Abstract: - Global Safety Needles Market to Reach $2. 9 Billion by 2027. - Amid the COVID-19 crisis, the global market for Safety Needles estimated at US$1. 8 Billion in the year 2020, is projected to reach a revised size of US$2.

New York, June 15, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Safety Needles Industry" - https://www.reportlinker.com/p06032819/?utm_source=GNW
9 Billion by 2027, growing at a CAGR of 6.9% over the analysis period 2020-2027. Active, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$1.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Passive segment is readjusted to a revised 6% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $493.2 Million, While China is Forecast to Grow at 10.4% CAGR
- The Safety Needles market in the U.S. is estimated at US$493.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$638.5 Million by the year 2027 trailing a CAGR of 10.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
- Other Types Segment to Record 6.2% CAGR
- In the global Other Types segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$176.7 Million in the year 2020 will reach a projected size of US$259.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$396.2 Million by the year 2027, while Latin America will expand at a 7.4% CAGR through the analysis period.

- Select Competitors (Total 42 Featured) -

  • B. Braun Melsungen AG

  • Becton

  • Cardinal Health

  • Dickinson and Company

  • Johnson & Johnson (Ethicon Inc.)

  • Nipro Corporation

  • Novo Nordisk A/S

  • Retractable Technologies, Inc.

  • Smiths Group Plc.

  • Terumo Corporation

  • Vygon SA




Read the full report: https://www.reportlinker.com/p06032819/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Safety Needles by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Safety Needles by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 3: World 15-Year Perspective for Safety Needles by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Active by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Active by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Active by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Passive by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Passive by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Passive by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Other Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Other Types by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Other Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Hospitals &
Ambulatory Surgery Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Hospitals & Ambulatory
Surgery Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Hospitals & Ambulatory
Surgery Centers by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2020 & 2027

Table 16: World Current & Future Analysis for Diabetic Patients
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Diabetic Patients by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Diabetic Patients by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Family Practice
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Family Practice by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Family Practice by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Psychiatry by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Psychiatry by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Psychiatry by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for Safety Needles by
Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 29: USA Historic Review for Safety Needles by Product
Type - Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 30: USA 15-Year Perspective for Safety Needles by Product
Type - Percentage Breakdown of Value Sales for Active, Passive
and Other Types for the Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for Safety Needles by
End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 32: USA Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for Safety Needles by End-Use -
Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

CANADA
Table 34: Canada Current & Future Analysis for Safety Needles
by Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 35: Canada Historic Review for Safety Needles by Product
Type - Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 36: Canada 15-Year Perspective for Safety Needles by
Product Type - Percentage Breakdown of Value Sales for Active,
Passive and Other Types for the Years 2012, 2020 & 2027

Table 37: Canada Current & Future Analysis for Safety Needles
by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 38: Canada Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for Safety Needles by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

JAPAN
Table 40: Japan Current & Future Analysis for Safety Needles by
Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 41: Japan Historic Review for Safety Needles by Product
Type - Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 42: Japan 15-Year Perspective for Safety Needles by
Product Type - Percentage Breakdown of Value Sales for Active,
Passive and Other Types for the Years 2012, 2020 & 2027

Table 43: Japan Current & Future Analysis for Safety Needles by
End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 44: Japan Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for Safety Needles by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

CHINA
Table 46: China Current & Future Analysis for Safety Needles by
Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 47: China Historic Review for Safety Needles by Product
Type - Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 48: China 15-Year Perspective for Safety Needles by
Product Type - Percentage Breakdown of Value Sales for Active,
Passive and Other Types for the Years 2012, 2020 & 2027

Table 49: China Current & Future Analysis for Safety Needles by
End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: China Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 51: China 15-Year Perspective for Safety Needles by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

EUROPE
Table 52: Europe Current & Future Analysis for Safety Needles
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 53: Europe Historic Review for Safety Needles by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Safety Needles by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 55: Europe Current & Future Analysis for Safety Needles
by Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 56: Europe Historic Review for Safety Needles by Product
Type - Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 57: Europe 15-Year Perspective for Safety Needles by
Product Type - Percentage Breakdown of Value Sales for Active,
Passive and Other Types for the Years 2012, 2020 & 2027

Table 58: Europe Current & Future Analysis for Safety Needles
by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: Europe Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 60: Europe 15-Year Perspective for Safety Needles by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

FRANCE
Table 61: France Current & Future Analysis for Safety Needles
by Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 62: France Historic Review for Safety Needles by Product
Type - Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 63: France 15-Year Perspective for Safety Needles by
Product Type - Percentage Breakdown of Value Sales for Active,
Passive and Other Types for the Years 2012, 2020 & 2027

Table 64: France Current & Future Analysis for Safety Needles
by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 65: France Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 66: France 15-Year Perspective for Safety Needles by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

GERMANY
Table 67: Germany Current & Future Analysis for Safety Needles
by Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 68: Germany Historic Review for Safety Needles by Product
Type - Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 69: Germany 15-Year Perspective for Safety Needles by
Product Type - Percentage Breakdown of Value Sales for Active,
Passive and Other Types for the Years 2012, 2020 & 2027

Table 70: Germany Current & Future Analysis for Safety Needles
by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 71: Germany Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 72: Germany 15-Year Perspective for Safety Needles by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

ITALY
Table 73: Italy Current & Future Analysis for Safety Needles by
Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 74: Italy Historic Review for Safety Needles by Product
Type - Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 75: Italy 15-Year Perspective for Safety Needles by
Product Type - Percentage Breakdown of Value Sales for Active,
Passive and Other Types for the Years 2012, 2020 & 2027

Table 76: Italy Current & Future Analysis for Safety Needles by
End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 77: Italy Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 78: Italy 15-Year Perspective for Safety Needles by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for Safety Needles by
Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 80: UK Historic Review for Safety Needles by Product Type -
Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 81: UK 15-Year Perspective for Safety Needles by Product
Type - Percentage Breakdown of Value Sales for Active, Passive
and Other Types for the Years 2012, 2020 & 2027

Table 82: UK Current & Future Analysis for Safety Needles by
End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: UK Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 84: UK 15-Year Perspective for Safety Needles by End-Use -
Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

SPAIN
Table 85: Spain Current & Future Analysis for Safety Needles by
Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 86: Spain Historic Review for Safety Needles by Product
Type - Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 87: Spain 15-Year Perspective for Safety Needles by
Product Type - Percentage Breakdown of Value Sales for Active,
Passive and Other Types for the Years 2012, 2020 & 2027

Table 88: Spain Current & Future Analysis for Safety Needles by
End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 89: Spain Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 90: Spain 15-Year Perspective for Safety Needles by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

RUSSIA
Table 91: Russia Current & Future Analysis for Safety Needles
by Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 92: Russia Historic Review for Safety Needles by Product
Type - Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 93: Russia 15-Year Perspective for Safety Needles by
Product Type - Percentage Breakdown of Value Sales for Active,
Passive and Other Types for the Years 2012, 2020 & 2027

Table 94: Russia Current & Future Analysis for Safety Needles
by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Russia Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 96: Russia 15-Year Perspective for Safety Needles by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 97: Rest of Europe Current & Future Analysis for Safety
Needles by Product Type - Active, Passive and Other Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: Rest of Europe Historic Review for Safety Needles by
Product Type - Active, Passive and Other Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 99: Rest of Europe 15-Year Perspective for Safety Needles
by Product Type - Percentage Breakdown of Value Sales for
Active, Passive and Other Types for the Years 2012, 2020 & 2027

Table 100: Rest of Europe Current & Future Analysis for Safety
Needles by End-Use - Hospitals & Ambulatory Surgery Centers,
Diabetic Patients, Family Practice, Psychiatry and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 101: Rest of Europe Historic Review for Safety Needles by
End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 102: Rest of Europe 15-Year Perspective for Safety
Needles by End-Use - Percentage Breakdown of Value Sales for
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses for the Years
2012, 2020 & 2027

ASIA-PACIFIC
Table 103: Asia-Pacific Current & Future Analysis for Safety
Needles by Geographic Region - Australia, India, South Korea
and Rest of Asia-Pacific Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2020 through 2027 and %
CAGR

Table 104: Asia-Pacific Historic Review for Safety Needles by
Geographic Region - Australia, India, South Korea and Rest of
Asia-Pacific Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 105: Asia-Pacific 15-Year Perspective for Safety Needles
by Geographic Region - Percentage Breakdown of Value Sales for
Australia, India, South Korea and Rest of Asia-Pacific Markets
for Years 2012, 2020 & 2027

Table 106: Asia-Pacific Current & Future Analysis for Safety
Needles by Product Type - Active, Passive and Other Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: Asia-Pacific Historic Review for Safety Needles by
Product Type - Active, Passive and Other Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 108: Asia-Pacific 15-Year Perspective for Safety Needles
by Product Type - Percentage Breakdown of Value Sales for
Active, Passive and Other Types for the Years 2012, 2020 & 2027

Table 109: Asia-Pacific Current & Future Analysis for Safety
Needles by End-Use - Hospitals & Ambulatory Surgery Centers,
Diabetic Patients, Family Practice, Psychiatry and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 110: Asia-Pacific Historic Review for Safety Needles by
End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 111: Asia-Pacific 15-Year Perspective for Safety Needles
by End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family
Practice, Psychiatry and Other End-Uses for the Years 2012,
2020 & 2027

AUSTRALIA
Table 112: Australia Current & Future Analysis for Safety
Needles by Product Type - Active, Passive and Other Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 113: Australia Historic Review for Safety Needles by
Product Type - Active, Passive and Other Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 114: Australia 15-Year Perspective for Safety Needles by
Product Type - Percentage Breakdown of Value Sales for Active,
Passive and Other Types for the Years 2012, 2020 & 2027

Table 115: Australia Current & Future Analysis for Safety
Needles by End-Use - Hospitals & Ambulatory Surgery Centers,
Diabetic Patients, Family Practice, Psychiatry and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 116: Australia Historic Review for Safety Needles by
End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 117: Australia 15-Year Perspective for Safety Needles by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

INDIA
Table 118: India Current & Future Analysis for Safety Needles
by Product Type - Active, Passive and Other Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 119: India Historic Review for Safety Needles by Product
Type - Active, Passive and Other Types Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 120: India 15-Year Perspective for Safety Needles by
Product Type - Percentage Breakdown of Value Sales for Active,
Passive and Other Types for the Years 2012, 2020 & 2027

Table 121: India Current & Future Analysis for Safety Needles
by End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 122: India Historic Review for Safety Needles by End-Use -
Hospitals & Ambulatory Surgery Centers, Diabetic Patients,
Family Practice, Psychiatry and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 123: India 15-Year Perspective for Safety Needles by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family Practice,
Psychiatry and Other End-Uses for the Years 2012, 2020 & 2027

SOUTH KOREA
Table 124: South Korea Current & Future Analysis for Safety
Needles by Product Type - Active, Passive and Other Types -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 125: South Korea Historic Review for Safety Needles by
Product Type - Active, Passive and Other Types Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 126: South Korea 15-Year Perspective for Safety Needles
by Product Type - Percentage Breakdown of Value Sales for
Active, Passive and Other Types for the Years 2012, 2020 & 2027

Table 127: South Korea Current & Future Analysis for Safety
Needles by End-Use - Hospitals & Ambulatory Surgery Centers,
Diabetic Patients, Family Practice, Psychiatry and Other
End-Uses - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 128: South Korea Historic Review for Safety Needles by
End-Use - Hospitals & Ambulatory Surgery Centers, Diabetic
Patients, Family Practice, Psychiatry and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 129: South Korea 15-Year Perspective for Safety Needles
by End-Use - Percentage Breakdown of Value Sales for Hospitals &
Ambulatory Surgery Centers, Diabetic Patients, Family
Practice, Psychiatry and Other End-Uses for the Years 2012,
2020 & 2027

REST OF ASIA-PACIFIC
Table 130: Rest of Asia-Pacific Current & Future Analysis for
Safety Needles by Product Type - Active, Passive and Other
Types - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR

Table 131: Rest of Asia-Pacific Historic Review for Safety

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032819/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001